首页> 外文期刊>Analytical Sciences >Separation and Determination of Process-Related Impurities of Erlotinib Using Reverse-Phase HPLC with a Photo-Diode Array Detector
【24h】

Separation and Determination of Process-Related Impurities of Erlotinib Using Reverse-Phase HPLC with a Photo-Diode Array Detector

机译:使用光电二极管阵列检测器的反相HPLC分离和确定厄洛替尼的过程相关杂质

获取原文
           

摘要

A simple and rapid reverse-phase high-performance liquid chromatographic (HPLC) method for the simultaneous separation and determination of erlotinib and its process-related impurities in bulk drugs has been developed. Five process-related impurities of erlotinib have been separated on an Inerstsil ODS-3V (C18) column and detected at 254 nm using a photo diode array (PDA). This HPLC method was successfully applied to the analysis of erlotinib bulk drug. The recoveries of erlotinib and process-related impurities were in the range of 92.86 – 106.23%, and found to be specific, precise and reliable for the determination of unreacted raw materials, intermediates in the reaction mixtures and bulk drugs.
机译:开发了一种简单,快速的反相高效液相色谱(HPLC)方法,用于同时分离和测定散装药物中的厄洛替尼及其过程相关杂质。已在Inerstsil ODS-3V(C18)色谱柱上分离出了五种与厄洛替尼相关的工艺相关杂质,并使用光电二极管阵列(PDA)在254 nm下进行了检测。该HPLC方法已成功地用于厄洛替尼原料药的分析。厄洛替尼和与工艺有关的杂质的回收率在92.86 – 106.23%的范围内,被发现对未反应的原料,反应混合物中的中间体和原料药的测定具有特异性,精确性和可靠性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号